Chemotherapy for Leukemia and Lymphoma

"Dexamethasone is a common medication used to treat pheochromocytomas. Additionally, this medication can be used to manage other conditions such as ulcerative colitis, certain types of viral eye infections, and varicella-zoster virus acute retinal necrosis."

"Currently, 2036 different clinical trials testing Dexamethasone are ongoing in 88 countries and 3496 cities. The first such trial began in 1997 and, sponsored by Alfacell, completed its Phase 3 drug approval stage with 300 participants. In the years since 1997, 4265 Dexamethasone trials have been conducted."

"The trial is based out of AdventHealth Orlando in Orlando, Florida, Yale University in New Haven, Connecticut, El Paso Children's Hospital in El Paso, Texas; as well as 100 other sites."

"The clinical trial in question is not presently looking for new patients, however, this may change in the future. The original posting date was 8/9/2010, with the most recent edit on 7/8/2022. Although this study is not recruiting candidates at this time, there are 5036 other studies presently accepting participants."

"Eligibility requirements for this clinical trial include having down syndrome and being between 1 and 30 years old. The total number of participants that the study is hoping to recruit is 9350 individuals."

"This trial is for patients aged 1 year to 30 years old. Out of 4251 trials for patients over 65 and 1129 trials for those under 18, this is the only study that meets the specified age range."

"Dexamethasone has received a rating of 3 from our team at Power. This means that, while it is a phase 3 trial medication, there is some data supporting its efficacy as well as multiple rounds of data supporting its safety."

"The first documented use of dexamethasone was in 1997 at Spectrum Health Hospital - Butterworth Campus. In the years since, 4265 similar studies have been completed with 2036 currently active. A large number of these active studies are based in Orlando, Florida."